Alogliptin + Metformin
Composition
This formulation contains alogliptin and Metformin as active ingrediant
Indications
This combination Formulation is used to treat type 2 diabetes mellitus.
Side effects
Common side effects may include diarrhea, nausea, vomiting, abdominal discomfort, and headache.
Precautions
Use with caution in patients with kidney disease, liver disease, or heart failure.
Contraindications
Contraindicated in patients having kidney disease, liver disease, or metabolic acidosis.
Dosage and administration
As directed by physician, Once or twice a daily with foods
Countries
Worldwide
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai